Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 500

1.

International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus.

Verweij PE, Ananda-Rajah M, Andes D, Arendrup MC, Brüggemann RJ, Chowdhary A, Cornely OA, Denning DW, Groll AH, Izumikawa K, Kullberg BJ, Lagrou K, Maertens J, Meis JF, Newton P, Page I, Seyedmousavi S, Sheppard DC, Viscoli C, Warris A, Donnelly JP.

Drug Resist Updat. 2015 Aug 7. pii: S1368-7646(15)00035-7. doi: 10.1016/j.drup.2015.08.001. [Epub ahead of print]

2.

Candida parapsilosis resistance to fluconazole: molecular mechanisms and in vivo impact in infected Galleria mellonella larvae.

Souza AC, Fuchs BB, Pinhati HM, Siqueira RA, Hagen F, Meis JF, Mylonakis E, Colombo AL.

Antimicrob Agents Chemother. 2015 Aug 10. pii: AAC.01177-15. [Epub ahead of print]

PMID:
26259795
3.

A novel Y319H mutation in CYP51C associated with azole resistance in Aspergillus flavus.

Paul RA, Rudramurthy SM, Meis JF, Mouton JW, Chakrabarti A.

Antimicrob Agents Chemother. 2015 Jul 27. pii: AAC.00637-15. [Epub ahead of print]

PMID:
26248359
4.

In Vitro Activity of Eight Antifungal Drugs Against a Global Collection of Genotyped Isolates of Exserohilum.

Chowdhary A, Hagen F, Curfs-Breuker I, Madrid H, de Hoog GS, Meis JF.

Antimicrob Agents Chemother. 2015 Aug 3. pii: AAC.01218-15. [Epub ahead of print]

PMID:
26239995
5.

Draft Genome Sequence of a Fluconazole-Resistant Candida auris Strain from a Candidemia Patient in India.

Sharma C, Kumar N, Meis JF, Pandey R, Chowdhary A.

Genome Announc. 2015 Jul 16;3(4). pii: e00722-15. doi: 10.1128/genomeA.00722-15.

6.

Erratum for Abdolrasouli et al., Genomic Context of Azole Resistance Mutations in Aspergillus fumigatus Determined Using Whole-Genome Sequencing.

Abdolrasouli A, Rhodes J, Beale MA, Hagen F, Rogers TR, Chowdhary A, Meis JF, Armstrong-James D, Fisher MC.

MBio. 2015 Jul 14;6(4):e00939. doi: 10.1128/mBio.00939-15. No abstract available.

7.

High prevalence of azole resistance in Aspergillus fumigatus isolates from high-risk patients.

Fuhren J, Voskuil WS, Boel CH, Haas PJ, Hagen F, Meis JF, Kusters JG.

J Antimicrob Chemother. 2015 Jul 9. pii: dkv177. [Epub ahead of print]

PMID:
26163402
8.

Direct molecular versus culture-based assessment of Gram-positive cocci in biopsies of patients with major abscesses and diabetic foot infections.

Stappers MH, Hagen F, Reimnitz P, Mouton JW, Meis JF, Gyssens IC.

Eur J Clin Microbiol Infect Dis. 2015 Sep;34(9):1885-92. doi: 10.1007/s10096-015-2428-4. Epub 2015 Jul 5.

9.

Trypanosoma cruzi Infection through the Oral Route Promotes a Severe Infection in Mice: New Disease Form from an Old Infection?

Barreto-de-Albuquerque J, Silva-dos-Santos D, Pérez AR, Berbert LR, de Santana-van-Vliet E, Farias-de-Oliveira DA, Moreira OC, Roggero E, de Carvalho-Pinto CE, Jurberg J, Cotta-de-Almeida V, Bottasso O, Savino W, de Meis J.

PLoS Negl Trop Dis. 2015 Jun 19;9(6):e0003849. doi: 10.1371/journal.pntd.0003849. eCollection 2015 Jun.

10.

In vitro antimicrobial susceptibility testing of human Brucella melitensis isolates from Qatar between 2014 - 2015.

Deshmukh A, Hagen F, Sharabasi OA, Abraham M, Wilson G, Doiphode S, Maslamani MA, Meis JF.

BMC Microbiol. 2015 Jun 16;15:121. doi: 10.1186/s12866-015-0458-9.

11.

Genomic Context of Azole Resistance Mutations in Aspergillus fumigatus Determined Using Whole-Genome Sequencing.

Abdolrasouli A, Rhodes J, Beale MA, Hagen F, Rogers TR, Chowdhary A, Meis JF, Armstrong-James D, Fisher MC.

MBio. 2015 Jun 2;6(3):e00536. doi: 10.1128/mBio.00536-15.

12.

Paradoxical Immune Responses in Non-HIV Cryptococcal Meningitis.

Panackal AA, Wuest SC, Lin YC, Wu T, Zhang N, Kosa P, Komori M, Blake A, Browne SK, Rosen LB, Hagen F, Meis J, Levitz SM, Quezado M, Hammoud D, Bennett JE, Bielekova B, Williamson PR.

PLoS Pathog. 2015 May 28;11(5):e1004884. doi: 10.1371/journal.ppat.1004884. eCollection 2015 May.

13.

Prevalence and mechanism of triazole resistance in Aspergillus fumigatus in a referral chest hospital in Delhi, India and an update of the situation in Asia.

Chowdhary A, Sharma C, Kathuria S, Hagen F, Meis JF.

Front Microbiol. 2015 May 8;6:428. doi: 10.3389/fmicb.2015.00428. eCollection 2015.

14.

Hip and knee arthroplasty: quo vadis?

Ho J, Meis JF, Nabuurs-Franssen M, Voss A.

Antimicrob Resist Infect Control. 2015 May 15;4:19. doi: 10.1186/s13756-015-0060-9. eCollection 2015.

15.

First description of azole-resistant Aspergillus fumigatus due to TR46/Y121F/T289A mutation in France.

Lavergne RA, Morio F, Favennec L, Dominique S, Meis JF, Gargala G, Verweij PE, Le Pape P.

Antimicrob Agents Chemother. 2015 Jul;59(7):4331-5. doi: 10.1128/AAC.00127-15. Epub 2015 Apr 27.

PMID:
25918139
16.

Detection and serotyping of pneumococci in community acquired pneumonia patients without culture using blood and urine samples.

Elberse K, van Mens S, Cremers AJ, Meijvis SC, Vlaminckx B, de Jonge MI, Meis JF, Blauwendraat C, van de Pol I, Schouls LM.

BMC Infect Dis. 2015 Feb 13;15:56. doi: 10.1186/s12879-015-0788-0.

17.

Multi-triazole-resistant Aspergillus fumigatus infections in Australia.

Kidd SE, Goeman E, Meis JF, Slavin MA, Verweij PE.

Mycoses. 2015 Jun;58(6):350-5. doi: 10.1111/myc.12324. Epub 2015 Apr 17.

PMID:
25885568
19.

Molecular epidemiology and in-vitro antifungal susceptibility of Aspergillus terreus species complex isolates in Delhi, India: evidence of genetic diversity by amplified fragment length polymorphism and microsatellite typing.

Kathuria S, Sharma C, Singh PK, Agarwal P, Agarwal K, Hagen F, Meis JF, Chowdhary A.

PLoS One. 2015 Mar 17;10(3):e0118997. doi: 10.1371/journal.pone.0118997. eCollection 2015.

20.

In vitro susceptibility patterns of clinically important Trichophyton and Epidermophyton species against nine antifungal drugs.

Badali H, Mohammadi R, Mashedi O, de Hoog GS, Meis JF.

Mycoses. 2015 May;58(5):303-7. doi: 10.1111/myc.12315. Epub 2015 Mar 10.

PMID:
25757042
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk